TMEM19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.21990000510198E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.73549999821421E-08 |
Normal-vs-Stage2 |
2.107800E-02 |
Normal-vs-Stage3 |
3.376500E-03 |
Normal-vs-Stage4 |
7.8675000000028E-05 |
Stage1-vs-Stage2 |
4.258800E-01 |
Stage1-vs-Stage3 |
7.560800E-01 |
Stage1-vs-Stage4 |
8.839000E-01 |
Stage2-vs-Stage3 |
6.969200E-01 |
Stage2-vs-Stage4 |
5.181000E-01 |
Stage3-vs-Stage4 |
8.566000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.292700000044E-06 |
Normal-vs-AfricanAmerican |
3.66628949421965E-12 |
Normal-vs-Asian |
2.616800E-01 |
Caucasian-vs-AfricanAmerican |
3.79740000000517E-05 |
Caucasian-vs-Asian |
6.741400E-01 |
AfricanAmerican-vs-Asian |
2.510100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.45080000002462E-06 |
Normal-vs-Female |
1.56959999997319E-07 |
Male-vs-Female |
6.233800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.89130957959105E-12 |
Normal-vs-Age(41-60Yrs) |
2.21640000019896E-07 |
Normal-vs-Age(61-80Yrs) |
6.45879999999766E-05 |
Normal-vs-Age(81-100Yrs) |
3.623600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.29920000005546E-06 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.84149999985451E-07 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.611750E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.720600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.676000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.637600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.362200E-04 |
Normal-vs-Grade 2 |
1.83125999999589E-05 |
Normal-vs-Grade 3 |
1.212030E-04 |
Normal-vs-Grade 4 |
1.18740000054629E-07 |
Grade 1-vs-Grade 2 |
2.400000E-01 |
Grade 1-vs-Grade 3 |
2.247800E-01 |
Grade 1-vs-Grade 4 |
8.653200E-01 |
Grade 2-vs-Grade 3 |
4.039400E-01 |
Grade 2-vs-Grade 4 |
1.345810E-01 |
Grade 3-vs-Grade 4 |
2.794300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.257700E-03 |
Normal-vs-ccB subtype |
2.15770000000504E-06 |
ccA subtype-vs-ccB subtype |
1.737640E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.379200E-04 |
Normal-vs-N1 |
2.658000E-01 |
N0-vs-N1 |
8.947800E-01 |
|
|